Lid Wiper Epitheliopathy Trial

Alcon Research187 enrolled

Overview

The purpose of this study is to evaluate the effect of contact lens lubricity on lid wiper epitheliopathy (LWE) in symptomatic contact lens wearers. LWE is defined as an alteration of that portion of the marginal conjunctival epithelium of the upper eyelid that wipes the ocular surface during blinking.

This study will be conducted in two stages. In Stage 1, participants will wear either spectacles or contact lenses for two weeks to determine the impact of interruption of contact lens wear on LWE. In Stage 2, a second cohort of participants will wear one of two contact lens brands for two weeks, and LWE and ocular discomfort will be compared.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

187

Conditions

Lid Wiper Epitheliopathy

Interventions

SpectaclesDEVICE

Per participant's habitual prescription

Delefilcon A contact lensesDEVICE

Silicone hydrogel single vision contact lenses

Etafilcon A contact lensesDEVICE

Hydrogel single vision contact lenses

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Sign Informed Consent document. * Severe lid wiper epitheliopathy (upper lid) in either eye. * Currently wearing spherical daily disposable soft contact lenses or daily wear soft contact lenses in both eyes with at least 3 months of contact lens wearing experience. * Symptomatic as determined by the SPEED questionnaire. * Willing to follow visit schedule. * Habitual contact lens power with the range of -1.00 to -6.00 diopters (D) with best corrected distance visual acuity greater than or equal to 20/25 in each eye. * Astigmatism less than or equal to 0.75D. * Possess spectacles which provide visual acuity of at least 20/25 in each eye. * Willing and able to complete daily diaries. * Other protocol-defined inclusion criteria may apply. Exclusion Criteria: * Eye injury within 12 weeks immediately prior to enrollment. * Any ocular condition that would contraindicate contact lens wear. * Any use of systemic or ocular medications that would contraindicate contact lens wear, as determined by the investigator. * Currently wearing toric or multifocal soft contact lenses. * Participation in a clinical study (including contact lens or contact lens care product) within the previous 30 days. * Routinely sleeps in lenses for at least 1 night per week. * Other protocol-defined exclusion criteria may apply.

Outcomes

Primary Outcomes

Stage 1: Percent of Eyes Experiencing at Least 1 Grade Reduction in LWE at 2 Weeks

LWE was measured by slit lamp evaluation of fluorescein and lissamine green staining of the upper eyelid. LWE was graded on a scale from 0 to 3, where 0=none and 3=severe. The percent of eyes experiencing at least a 1 grade reduction in LWE (from baseline) at the 2-week visit was compared between groups. One eye (study eye) contributed to the analysis.

Time frame: Baseline, Week 2

Stage 2: Percent of Eyes Experiencing at Least 1 Grade Reduction in LWE at 2 Weeks

This outcome measure was not evaluated since primary efficacy was not demonstrated.

Time frame: Baseline, Week 2

Secondary Outcomes

Stage 2: Change From Baseline in Ocular Discomfort Score (as Measured by SPEED) at 2 Weeks

This outcome measure was not evaluated since primary efficacy was not demonstrated.

Time frame: Baseline, Week 2

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.